Mary Kay Inc. Recommits to Responsible and Sustainable Water Management Following World Water Day 2022
24.3.2022 15:02:00 EET | Business Wire | Press release
Water is essential to life in all its forms and to the ongoing development of a healthy and sustainable future. According to the World Economic Forum, environmental risks and the impact on natural ecosystems and resources continues to be a top global risk.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220324005126/en/
Richard R. Rogers (R3) Manufacturing/R&D Center in Lewisville, Texas, U.S.A (Photo: Mary Kay Inc.)
This World Water Day, Mary Kay Inc. recommits to responsible and sustainable water management to ensure the ongoing availability of water as an essential resource to meet the needs of the environment and communities around the world.
Water is at the heart of Mary Kay’s sustainability strategy and crucial to its manufacturing processes. Implementing good water stewardship principles is critical for Mary Kay to reach our sustainability goals. We strive to ensure water use for human and economic needs does not disrupt sustainable water cycles or cause ongoing harm to nature and biodiversity. Recent water efforts at Mary Kay facilities include:
- Water use at U.S. Mary Kay-owned facilities decreased 36% from 2012-2017.
-
At Mary Kay’s manufacturing facility in Hangzhou, China, significant strides toward water conservation include:
- Reduced potable water use by 34%, which saves approximately 913,480 gallons of potable water per year.
- Reverse Osmosis (RO) reject water reuse: The purifying water equipment produces a large amount of concentrated water discharge in the operation process. By collecting concentrated water and passing it through the circulation system, concentrated water will be reused through the fire tower and air-cooling tower system as a supplementary water source.
- Wastewater treatment upgrade: To mitigate the environmental impact of wastewater in its manufacturing processes, Mary Kay China invested in an advanced membrane bioreactor (MBR) process using existing infrastructure to improve the capacity of wastewater treatment and reduce sludge discharge by 40%.
“As a global sustainability advocate, Mary Kay is dedicated to playing an important role in collective efforts to cause no harm to the environment and to ensure communities and economies prosper,” said Deborah Gibbins, Chief Operating Officer at Mary Kay Inc. “Mary Kay will continue to build upon its progress and work toward its commitment of reducing water utilization in our manufacturing processes by 30% by the year 2030 versus a 2020 baseline per kilogram bulk produced. Achieving Alliance for Water Stewardship (AWS) Core Certification for Mary Kay manufacturing facilities in the U.S. and China will help move us closer to our goals.”
Several key components of Mary Kay’s decade of action include:
- A current signatory of the UN Ocean Principles and CEO Water Mandate.
-
Continuing its 32-year partnership with The Nature Conservancy and supporting 11 global water projects in 2022 focusing on:
- Global ocean protection to improve ocean health for nature and people;
- Restoring Asia Pacific Shellfish Reefs in Australia, Hong Kong, China, the Coral Triangle, and the Cakaulevu Reef (also called the Great Sea Reef);
- Supporting Women Leaders in The Pacific in Papua New Guinea (Mangroves, Women, and Markets) and the Solomon Islands (Community Health and Resilience);
- Coastal Conservation and Restoration in the Gulf Coast (Protecting the Gulf Coast Coastal Wetlands);
- Improving Fisheries in Mexico (Improving Fisheries and Empowering Communities); and
- Collaborating with partners in Europe supporting native oyster restoration projects in England, Scotland, Ireland, France, the Netherlands, Germany, and Sweden.
- Joining Alliance for Water Stewardship and working to achieve certification of our two manufacturing facilities by 2025.
To read more about Mary Kay’s commitment to sustainability, visit marykayglobal.com/sustainability and download Mary Kay’s global sustainability strategy, Enriching Lives Today for a Sustainable Tomorrow.
About Mary Kay Inc.
One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty company in 1963 with one goal: enriching women’s lives. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. As an entrepreneurship development company, Mary Kay is committed to empowering women on their journey to economic independence through education, mentorship, advocacy, networking, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in enriching lives today for a sustainable tomorrow, partnering with organizations from around the world focusing on promoting business excellence, supporting cancer research, advancing gender equality, protecting survivors from domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Learn more at marykayglobal.com, find us on Facebook, Instagram, and LinkedIn or follow us on Twitter.
About The Nature Conservancy
The Nature Conservancy is a global conservation organization dedicated to conserving the lands and waters on which all life depends. Guided by science, we create innovative, on-the-ground solutions to our world's toughest challenges so that nature and people can thrive together. We are tackling climate change, conserving lands, waters and oceans at an unprecedented scale, providing food and water sustainably and helping make cities more sustainable. Working in 79 countries and territories, we use a collaborative approach that engages local communities, governments, the private sector, and other partners. To learn more, visit www.nature.org or follow @nature_press on Twitter.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220324005126/en/
Contact information
Mary Kay Inc. Corporate Communications
marykay.com/newsroom
972.687.5332 or media@mkcorp.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 11:22:00 EET | Press release
Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh
Incyte Announces the European Commission Approval of Zynyz ® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 23:42:00 EET | Press release
Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meury, President and Chief Executive Officer, Incyte. “As the first PD-1 immunotherapy approved in Europe in combination with platinum-based chemotherapy in the first-line setting, Zynyz helps expand the standard-of-care options available to clinicians and underscores our commitment to delivering innovative medicines that can have an impact for patients.” The EC decision follows the January 2026 positive opinion received from the European Medicines Agency’s Committee f
Dfns Launches Payouts6.3.2026 22:27:00 EET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 21:23:00 EET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 19:30:00 EET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
